Medical treatment options in patients with metastatic renal cell carcinoma.
Haferkamp
A
A
Hohenfellner
M
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D004791:Enzyme Inhibitors; D020794:Receptor Protein-Tyrosine Kinases